A measure proposed by a bipartisan group of senators Friday would give the FDA increased regulatory control over compounding pharmacies that distribute products to other states. The bill would draw a line between compounding pharmacies that make drugs for doctors to keep for future use, like the New England Compounding Center, and compounders that make products on a per-prescription and per-patient basis. "This bill will enhance protections for patients taking compounded drugs and help prevent crises like last year's tragic meningitis outbreak," said Sen. Tom Harkin, D-Iowa.

Full Story:

Related Summaries